FALLON LYNNETTE C sold 9.5% of their position (5.09K shares) of CLEARPOINT NEURO, INC. on the open market
Open‑market sale worth $56.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/21/2026ACC: 0001193125-26-234575
-5.09K
Net shares
Net seller
$56.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.42K acquired · 17.51K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.42K
Price / share
—
Trade value
—
% of position
30.4%
5/19/2026
40.90K→53.32K
Common Stock
Direct
Shares
−5.09K
Price / share
$11.14
Trade value
$56.71K
% of position
9.5%
5/20/2026
53.32K→48.23K
Total
Net shares
+7.33K
Net value
-$56.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/19/2026 | M · Option Exercise | +12.42K | — | — | 30.4% | 40.90K | 53.32K |
| Common Stock Direct | 5/20/2026 | S · Sale | −5.09K | $11.14 | $56.71K | 9.5% | 53.32K | 48.23K |
| Total | +7.33K | -$56.71K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
12.42K shares
Shares
−12.42K
Strike price
Held after
0.00
Exercisable
—
5/19/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock12.42K shares | 5/19/2026 | M · Option Exercise | −12.42K | — | 0.00 |